11 February 2026 - BioMarin has today announced Health Canada has granted a Notice of Compliance with Conditions for Voxzogo (vosoritide for injection), the only approved medicine for eligible patients with achondroplasia in Canada.

Achondroplasia is the most common form of dwarfism, affecting about 1 in 25,000 live births.

Read BioMarin press release